HI
IBB icon

Honeywell International’s iShares Biotechnology ETF IBB Stock Holding History

Honeywell International’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-135,000
Closed -$11.9M – 188
2016
Q4 		$11.9M Buy
+135,000
New +$12.3M 0.4% 100
2015
Q4 		– Sell
-204,900
Closed -$20.7M – 204
2015
Q3 		$20.7M Buy
204,900
+72,900
+55% +$8.74M 0.56% 77
2015
Q2 		$16.2M Buy
+132,000
New +$15.8M 0.4% 110
2014
Q4 		– Sell
-223,500
Closed -$20.4M – 190
2014
Q3 		$20.4M Sell
223,500
-1,500
-0.7% -$132K 0.48% 88
2014
Q2 		$19.3M Buy
+225,000
New +$17.7M 0.44% 95

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Honeywell International's IBB Position: Q1 2017 in Review

Honeywell International sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 135,000 shares — an estimated $11.9M sold.

Honeywell International first reported a position in IBB in Q2 2014 and held it in 5 quarters. The position peaked at $20.7M in Q3 2015. 521 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

  • Honeywell International reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
  • Honeywell International sold 135,000 iShares Biotechnology ETF shares in Q1 2017, an estimated $11.9M.
  • Honeywell International first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 5 quarters.
  • Honeywell International's iShares Biotechnology ETF position peaked at $20.7M in Q3 2015.
  • 521 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Honeywell International's 13F filing for Q1 2017, filed 1 May 2017.